Suppr超能文献

使用贝叶斯预测法评估重症患者治疗最初24小时内万古霉素的曲线下面积及药代动力学参数

Vancomycin Area under the Curve and Pharmacokinetic Parameters during the First 24 Hours of Treatment in Critically Ill Patients using Bayesian Forecasting.

作者信息

Pongchaidecha Manat, Changpradub Dhitiwat, Bannalung Kanjana, Seejuntra Kajeewan, Thongmee Sutthanuch, Unnual Aminta, Santimaleeworagun Wichai

机构信息

Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.

Division of Infectious Diseases, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.

出版信息

Infect Chemother. 2020 Dec;52(4):573-582. doi: 10.3947/ic.2020.52.4.573. Epub 2020 Nov 27.

Abstract

BACKGROUND

Currently, the achievement of the target area under the curve (AUC)/minimum inhibitory concentration ratio during the first 24 - 48 h of treatment is associated with reduced 30-day mortality and greater microbiological eradication in patients with methicillin-resistant bacteremia. This study aimed to determine the AUC and pharmacokinetic parameters on the first day of vancomycin administration based on the Bayesian theorem to optimize the dosing regimen in critically ill patients.

MATERIALS AND METHODS

This retrospective study included participants meeting the following criteria: 1) ≥18 years old; 2) receipt of at least one dose of vancomycin; 3) measurement of 2 vancomycin serum concentrations during the first 24 h of treatment; and 4) an intensive care unit admission, mechanical ventilator use, or an Acute Physiology and Chronic Health Evaluation II score >15 points. The AUC on day 1 of treatment and the estimated vancomycin pharmacokinetic parameters were measured using PrecisePK software based on the Bayesian theorem.

RESULTS

We obtained 132 vancomycin concentrations from 66 patients. The vancomycin pharmacokinetic parameters were as follows: AUC, 571.09 (± standard deviation [SD] 188.62) mg/L·h; clearance (CL), 2.97 (± SD 1.81) L/h; volume of distribution (Vd), 50.60 (± SD 13.91) L; elimination rate constant, 0.062 (± SD 0.039) h; and half-life, 18.19 (± SD 15.96) h. Focusing on the vancomycin loading dose, AUC 400 - 600 was achieved in 41.7, 46.1, 44.4, and 26.3% of patients with loading doses of <20, 20 - 24.9, 25 - 30, and >30 mg/kg, respectively. Whereas AUC ≥521 was achieved in 50, 50, 77.8, and 84.2% of patients with loading doses of <20, 20 - 24.9, 25 - 30, and >30 mg/kg, respectively. The CL of vancomycin was correlated with creatinine CL, whereas the Vd of vancomycin was significantly correlated with age and body weight.

CONCLUSION

This study revealed that the higher Vd and CL values on the first day of vancomycin therapy were found in critically ill patients. Additionally, a higher vancomycin loading dose (25 - 30 mg/kg) might be required to achieve target of AUC during early phase of administration for critically ill patients.

摘要

背景

目前,在耐甲氧西林菌血症患者治疗的最初24 - 48小时内,达到曲线下面积(AUC)/最低抑菌浓度比值的目标与30天死亡率降低及更高的微生物清除率相关。本研究旨在基于贝叶斯定理确定万古霉素给药第一天的AUC和药代动力学参数,以优化重症患者的给药方案。

材料与方法

这项回顾性研究纳入了符合以下标准的参与者:1)年龄≥18岁;2)接受至少一剂万古霉素;3)在治疗的最初24小时内测量2次万古霉素血清浓度;4)入住重症监护病房、使用机械通气或急性生理与慢性健康状况评分II>15分。使用基于贝叶斯定理的PrecisePK软件测量治疗第一天的AUC和估计的万古霉素药代动力学参数。

结果

我们从66例患者中获得了132次万古霉素浓度。万古霉素药代动力学参数如下:AUC为571.09(±标准差[SD]188.62)mg/L·h;清除率(CL)为2.97(±SD 1.81)L/h;分布容积(Vd)为50.60(±SD 13.91)L;消除速率常数为0.062(±SD 0.039)h;半衰期为18.19(±SD 15.96)h。关注万古霉素负荷剂量,负荷剂量<20、20 - 24.9、25 - 30和>30 mg/kg的患者中,分别有41.7%、46.1%、44.4%和26.3%达到AUC 400 - 600。而负荷剂量<20、20 - 24.9、25 - 30和>30 mg/kg的患者中,分别有50%、50%、77.8%和84.2%达到AUC≥521。万古霉素的CL与肌酐清除率相关,而万古霉素的Vd与年龄和体重显著相关。

结论

本研究表明,重症患者在万古霉素治疗第一天的Vd和CL值较高。此外,对于重症患者,在给药早期可能需要更高的万古霉素负荷剂量(25 - 30 mg/kg)以达到AUC目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f641/7779987/862369d7f2a2/ic-52-573-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验